Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | Susan E. Smith, Rehana Bagodiya, Phuong Luong, Sakshi Shinde, Christopher M. Bland, Christopher Barry, Michael G. Bartlett, Nicholas R. Fox, Trisha N. Branan |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
di: Andrew J. Webb, et al.
Pubblicazione: (2025)
di: Andrew J. Webb, et al.
Pubblicazione: (2025)
Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
di: Ryusei Mikami, et al.
Pubblicazione: (2026)
di: Ryusei Mikami, et al.
Pubblicazione: (2026)
Intravenous Regular Insulin for Treatment of Hyperkalemia in Overweight Patients
di: Denise Kelley, et al.
Pubblicazione: (2025)
di: Denise Kelley, et al.
Pubblicazione: (2025)
Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab
di: Amber N. Navarra, et al.
Pubblicazione: (2025)
di: Amber N. Navarra, et al.
Pubblicazione: (2025)
Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report
di: Atif Siddiqui
Pubblicazione: (2024)
di: Atif Siddiqui
Pubblicazione: (2024)
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: João Gama Marques, et al.
Pubblicazione: (2025)
di: João Gama Marques, et al.
Pubblicazione: (2025)
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)
di: Atif Siddiqui
Pubblicazione: (2025)
Comparison of Subcutaneous Versus Intravenous Filgrastim in Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Study
di: Glenn Chang, et al.
Pubblicazione: (2025)
di: Glenn Chang, et al.
Pubblicazione: (2025)
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns
di: Ronald G. Hall, et al.
Pubblicazione: (2025)
di: Ronald G. Hall, et al.
Pubblicazione: (2025)
Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients
di: Rashmi J. Hemani, et al.
Pubblicazione: (2026)
di: Rashmi J. Hemani, et al.
Pubblicazione: (2026)
Intravenous thrombolysis for patients with acute ischemic stroke while receiving a direct oral anticoagulant: A systematic review and meta‐analysis
di: Megan Z. Roberts, et al.
Pubblicazione: (2025)
di: Megan Z. Roberts, et al.
Pubblicazione: (2025)
Correction to “Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐and Full‐Thickness Skin Burns”
Pubblicazione: (2025)
Pubblicazione: (2025)
Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)
di: Keith A. Rodvold
Pubblicazione: (2026)
Bayesian Dosing Simulator ( BDS ): A Pharmacokinetic Modeling Tool for Optimized Antibiotic Therapy
di: Adrian Valadez, et al.
Pubblicazione: (2026)
di: Adrian Valadez, et al.
Pubblicazione: (2026)
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
di: Trisha Matsuura, et al.
Pubblicazione: (2025)
di: Trisha Matsuura, et al.
Pubblicazione: (2025)
Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
di: Milre M. Matherne, et al.
Pubblicazione: (2026)
di: Milre M. Matherne, et al.
Pubblicazione: (2026)
Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns
di: Jay D. Olivet, et al.
Pubblicazione: (2025)
di: Jay D. Olivet, et al.
Pubblicazione: (2025)
Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
di: Youjun Chen, et al.
Pubblicazione: (2025)
di: Youjun Chen, et al.
Pubblicazione: (2025)
Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity
di: Yoshihiko Matsuki, et al.
Pubblicazione: (2026)
di: Yoshihiko Matsuki, et al.
Pubblicazione: (2026)
Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem‐Resistant Acinetobacter baumannii Bacteremia: A Case Report
di: Dan Ilges, et al.
Pubblicazione: (2025)
di: Dan Ilges, et al.
Pubblicazione: (2025)
Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)
Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study
di: Arden R. Barry, et al.
Pubblicazione: (2025)
di: Arden R. Barry, et al.
Pubblicazione: (2025)
Updates in chronic kidney disease management: A systematic review
di: Amina Ammar, et al.
Pubblicazione: (2025)
di: Amina Ammar, et al.
Pubblicazione: (2025)
Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data
di: Ashna Talwar, et al.
Pubblicazione: (2024)
di: Ashna Talwar, et al.
Pubblicazione: (2024)
Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
di: Christen J. Arena, et al.
Pubblicazione: (2025)
di: Christen J. Arena, et al.
Pubblicazione: (2025)
Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
di: Brian Murray, et al.
Pubblicazione: (2026)
di: Brian Murray, et al.
Pubblicazione: (2026)
Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Pubblicazione: (2024)
Pubblicazione: (2024)
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)
di: Lisa T. Hong, et al.
Pubblicazione: (2024)
Pharmacotherapeutic Controversies During Temperature Control After Out‐of‐Hospital Cardiac Arrest: A Semi‐Structured Literature Review
di: Christy Cecil Forehand, et al.
Pubblicazione: (2026)
di: Christy Cecil Forehand, et al.
Pubblicazione: (2026)
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)
di: Alexandre Duong, et al.
Pubblicazione: (2024)
Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)
Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)
di: Seonga Song, et al.
Pubblicazione: (2026)
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)
di: Jiwon Kim, et al.
Pubblicazione: (2025)
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)
di: Nicolette Centanni, et al.
Pubblicazione: (2025)
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)
Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)
di: Amanda Massmann, et al.
Pubblicazione: (2025)
In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)
di: C. Lindsay DeVane
Pubblicazione: (2025)
Documenti analoghi
-
External Validation of the Fraser Equation for Estimation of Free Valproate Concentrations in Critically Ill Adults
di: Andrew J. Webb, et al.
Pubblicazione: (2025) -
Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
di: Ryusei Mikami, et al.
Pubblicazione: (2026) -
Intravenous Regular Insulin for Treatment of Hyperkalemia in Overweight Patients
di: Denise Kelley, et al.
Pubblicazione: (2025) -
Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab
di: Amber N. Navarra, et al.
Pubblicazione: (2025) -
Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report
di: Atif Siddiqui
Pubblicazione: (2024)